Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study is a collaboration between the University of Pennsylvania, the Philadelphia Prison System, and the North East Treatment Center (NETSteps). It purpose is to study the impact of an injectable opiate addiction medication (extended release naltrexone) given before reentry into the community that might help to improve reconnection to healthcare and other support systems, and possibly help reduce recidivism.
Epistemonikos ID: 487100346d7a5de188a1e95e5b285a208851b834
First added on: May 12, 2024